Vera Therapeutics (VERA) Profit After Tax (2020 - 2026)
Vera Therapeutics (VERA) posted Profit After Tax of -$121.0 million for Q1 2026, down 32.86% on a QoQ basis from -$91.1 million in Q4 2025, and down 134.13% year-over-year from $354.6 million in Q1 2025.
Vera Therapeutics (VERA) Profit After Tax (2020 - 2026) Analysis & Trends
Vera Therapeutics' Profit After Tax history runs 7 years deep, the most recent figure standing at -$121.0 million for Q1 2026.
- Quarterly Profit After Tax fell 134.13% year-over-year to -$121.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$368.6 million (down 111.88% YoY) and the FY2025 annual result came in at -$299.6 million, down 96.92% from the prior year.
- Profit After Tax was -$121.0 million for Q1 2026 at Vera Therapeutics, down from -$91.1 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$14.9 million in Q2 2022 and bottomed at -$121.0 million in Q1 2026.
- A 5-year average of -$44.5 million and a median of -$32.4 million in 2022 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax plunged 332.15% — and 2023, when it advanced 21.55%.
- Vera Therapeutics' Profit After Tax stood at -$32.4 million in 2022, then grew by 21.55% to -$25.4 million in 2023, then sank by 70.94% to -$43.4 million in 2024, then plunged by 109.78% to -$91.1 million in 2025, then plunged by 32.86% to -$121.0 million in 2026.
- Business Quant data shows VERA's Profit After Tax at -$121.0 million in Q1 2026, -$91.1 million in Q4 2025, and -$79.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Vera Therapeutics | 2.55 Bn | 2.55 Bn | - | -121.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -121.03 Mn |
| Dec 31, 2025 | -91.10 Mn |
| Sep 30, 2025 | -79.94 Mn |
| Jun 30, 2025 | -76.53 Mn |
| Mar 31, 2025 | -51.69 Mn |
| Dec 31, 2024 | -43.43 Mn |
| Sep 30, 2024 | -45.14 Mn |
| Jun 30, 2024 | -33.71 Mn |
| Mar 31, 2024 | -28.38 Mn |
| Dec 31, 2023 | -25.40 Mn |
| Sep 30, 2023 | -20.10 Mn |
| Jun 30, 2023 | -20.16 Mn |
| Mar 31, 2023 | -30.07 Mn |
| Dec 31, 2022 | -32.38 Mn |
| Sep 30, 2022 | -24.81 Mn |
| Jun 30, 2022 | -14.85 Mn |
| Mar 31, 2022 | -17.09 Mn |
| Dec 31, 2021 | -16.85 Mn |
| Sep 30, 2021 | -7.61 Mn |
| Jun 30, 2021 | -3.44 Mn |